Skip to main content

Table 4 TG and Non-HDLC at each visit during treatment In 3 non-responders, where the Lovaza sequence was 4, 8,12, 4, 4, 4, 4 g/day

From: Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy

Visit

Dosage (g/day)

TG (mg/dl)

Non-HDLC (mg/dl)

Mean ± SD

median

p vs Visit 0

Mean ± SD

median

p vs Visit 0

0

0

1369 ±950

859

 

256 ±79

221

 

1

4

970 ±328

1154

 

258 ±121

229

 

2

8

1086 ±348

1190

 

235 ±86

199

 

3

12

1260 ±108

1290

 

242 ±121

211

 

4

4

1693 ±816

1650

 

301 ±85

347

 

5

4

1233 ±255

1360

 

248 ±86

237

 

6

4

1522 ±1065

1060

 

263 ±51

266

 

7

4

1760 ±71

1760

 

246 ±42

245